Skip to content

A randomized clinical trial for determining the efficacy and safety of acupressure hand- and foot- reflexology in addition to the anti-epileptic drugs (AEDs) compared with AEDs alone in the management of the patients with intractable epilepsy: a multicenter randomized clinical trial

Determination of efficacy and safety of reflexology therapy for the patients with intractable epilepsy: a multicenter randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005422
Enrollment
120
Registered
2015-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Intractable Epilepsy

Interventions

Intervention1: Anti-epileptic Drugs (AEDs)& real Reflexology therapy: The intervention will be done by the real or placebo Reflexology therapy in active group or control group respectively. Duration o

Sponsors

Department of Biotechnology NER DIVISION
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •The patients who will follow the following conditions will be included in the trial: •They should be the residents within 100 km around each of the centers. This is required because the response of the patients will be required to be monitored. •During the period of initial 1week, the patients together with caregivers of both arms will be admitted in the centre for training and recording all the clinical parameters at the baseline •The patients who will be able to have the therapy done by their caregivers. •The patients who will under the age group as mentioned above. •Either of sex •Patients with a minimum 2 seizures per month •The patients who fulfill the criteria for epileptic seizure •On 2 AEDs with at least one newer AED with an observation for a period of 6 months in each combination (prior to admitting the patients in the trial) •The patients who will not refuse but will be willing to submit, of their own, the filled-in informed consent proforma.

Exclusion criteria

Exclusion criteria: •Any kind of organ removal from the patientâ??s body due to any reason •Malignancy of any kind •Brain tumor •Tuberculosis •HIV- infection •Patients with progressive etiology of epilepsy •The patients who will refuse to submit the filled-in informed consent proforma.

Design outcomes

Primary

MeasureTime frame
a. Percentage in Seizure frequency reduction (R) b.Quality of life in epilepsy (QOLIE)QOLIE-31 : for ages 18 yrs to 60yrs Child behaviour check list: for ages 5 to 6 years and 6 to 18 yearsTimepoint: 6 months

Secondary

MeasureTime frame
â?¢Average no. of AEDs during last 3months prior to trial â?¢Change in number and type of AEDs during follow-up period â?¢Side effects of AEDs and reflexology â?¢Difficulty/pain in lower- limb movement by visual analogue Scale (VAS) at the end of follow-up w.r.t. that at base line â?¢Abnormalities to be observed in the reflex areas â?¢Genetic history by drawing the family tree in individual patient. â?¢Control of urine and Sleep pattern â?¢Digestive system functionTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Mrs Krishna Dalal

All India Institute of Medical Sciences

drkrishnadalal@gmail.com01126593215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026